Connor, Clark & Lunn Investment Management (CC&L)’s Crescent Biopharma CBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $542K | Buy |
|
|||||
|
2023
Q4 | $338K | Sell |
|
|||||
|
2023
Q3 | $224K | Sell |
|
|||||
|
2023
Q2 | $272K | Sell |
|
|||||
|
2023
Q1 | $200K | Buy |
|
|||||
|
2022
Q4 | $198K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $103K | Sell |
|
|||||
|
2021
Q4 | $172K | Buy |
|
|||||
|
2021
Q3 | $246K | Buy |
|
|||||
|
2021
Q2 | $247K | Sell |
|
|||||
|
2021
Q1 | $385K | Sell |
|
|||||
|
2020
Q4 | $482K | Buy |
|
|||||
|
2020
Q3 | $347K | Buy |
|
|||||
|
2020
Q2 | $353K | Sell |
|
|||||
|
2020
Q1 | $298K | Sell |
|
|||||
|
2019
Q4 | $701K | Sell |
|
|||||
|
2019
Q3 | $575K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $99K | Sell |
|
|||||
|
2016
Q2 | $115K | Sell |
|
|||||
|
2016
Q1 | $104K | Sell |
|
|||||
|
2015
Q4 | $108K | Buy |
|
|||||
|
2015
Q3 | $100K | Buy |
|
|||||
|
2015
Q2 | $116K | Buy |
|
|||||
|
2015
Q1 | $112K | Buy |
|